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alkaloids from Triclisia subcordata induce
cytotoxicity and apoptosis in ovarian cancer cell
lines†‡
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Falko P. Drijfhout,c James McCullagh,d Timothy W. D. Claridge, d Alan Richardsona
and Wen-Wu Li *a
Triclisia subcordata Oliv (Menispermeaceae) is used in herbal medicine for the treatment of cancer and
other diseases in Africa. This study aims to isolate minor alkaloids present in this plant and assay their
cytotoxic activities. Isochondodendrine and 20-norcocsuline as two minor alkaloids together with the
abundant cycleanine were isolated and identiﬁed by mass spectrometry and NMR spectroscopy. Both
isochondodendrine and 20-norcocsuline exhibited in vitro cytotoxicity in four ovarian cancer cell lines
(A2780, IGROV-1, OVCAR-8, and OVCAR-4) with IC50 ranges of 3.5–17 mM and 0.8–6.2 mM respectively.
These alkaloids showed mostly slightly weaker potencies when tested using normal human ovarian
epithelial cells, IC50 ¼ 10.5  1.2 mM and 8.0  0.2 mM for isochondodendrine and 20-norcocsuline,
respectively. The alkaloids induced apoptosis in ovarian cancer cells because they activated caspases 3/7,
induced cleavage of PARP, increased the subG1 population in cell cycle analysis and increased Annexin
V/propidium iodide staining. These observations suggest that isochondodendrine and 20-norcocsuline
contributing to the cytotoxic activity of T. subcordata may be suitable starting points for the future
development of novel therapeutics to treat ovarian cancer.Introduction
Cancer is among the most life-threatening diseases globally.
Ovarian cancer is one of the most diﬃcult cancers to eﬀectively
treat because of the development of resistance to available
chemotherapeutic agents such as cisplatin and paclitaxel,
therefore alternative therapeutics with novel mechanisms of
action are urgently needed. Natural products and traditional
medicines have been recognized for their major applications in
the identication of drug leads and drugs for the treatment of
many diseases including ovarian cancer.1–4 Numerous phyto-
chemicals and their semi-synthetic derivatives have been
approved as anticancer drugs including the well-known pacli-
taxel, irinotecan, and toptecan.1Many others are currently being
evaluated in clinical and preclinical studies.3 Because of theiredicine, Keele University, Stoke-on-Trent,
: +44 (0)1782 674382
sity of Port Harcourt, Nigeria
niversity, Staﬀordshire, ST5 5BG, UK
f Oxford, Oxford, OX1 3TA, UK
ational Conference on the Mechanism
.
tion (ESI) available. See DOI:
1diversity in both their chemical structure and mechanisms of
action, searching for novel drugs from medicinal plants is still
a viable and promising approach.1,5
Triclisia subcordata Oliv (Menispermeaceae) is an African
medicinal plant. It is used for the treatment of breast cancer in
Nigeria.6 T. subcordata has been reported to possess cytotoxic,7,8
anti-ulcer,9 antihistamine, and antimicrobial activities.10
Previous reports have identied some of the pharmacologically
active components of T. subcordata including bisbenzylisoqui-
noline (BBIQ) alkaloids, tricordatine,11 fangchinoline,12 and
tetrandrine.13 The BBIQ alkaloids are a large group of plant-
derived natural products demonstrating a plethora of biolog-
ical activities.14 For example, tetrandrine, originally isolated
from a Chinese medicinal plant – Stephania tetrandra S Moore
(Fen-Fang-Ji), inhibits cancer cell proliferation via apoptosis
induction, angiogenesis, migration and invasion; reverses
multi-drug resistance; and enhances radiation sensitization.15,16
We previously isolated and identied a major BBIQ alkaloid-
cycleanine from T. subcordata which showed in vitro anti-
ovarian cancer activity via bioassay guided fractionation.7,8
This study focused on isolation and structural identication
of additional bioactive compounds of T. subcordata and evalu-
ation of their in vitro cytotoxicity in ovarian cell lines by
measuring their activity in cell growth and viability assays.17 AThis journal is © The Royal Society of Chemistry 2017
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View Article Onlinepanel of assays were used to conrm that the compounds
induced apoptosis, including measurement of caspase 3/7
activity, assessing poly(ADP-ribose) polymerase (PARP)
cleavage, Annexin V and propidium iodide (PI) staining.
The results demonstrate that isochondodendrine and 20-nor-
cocsuline are likely to contribute to the cytotoxic eﬀects of
T. subcordata extracts.Results
Isolation and identication of isochondodendrine and
20-norcocsuline
Three alkaloids were extracted, puried and isolated from T.
subcordata (Fig. S1 and S2‡), which showed positive with theFig. 1 Chemical structures of cycleanine (1), isochondodendrine (2) and
Fig. 2 Concentration versus response curves of isochondodendrine (2) in
and OVCAR-8 (D) cells after treatment for 72 h. C on the x-axis represen
mean  standard error of the mean (SEM) (n ¼ 5).
This journal is © The Royal Society of Chemistry 2017Dragendorﬀ's assay. The purity of each alkaloid was more than
95%. Their chemical structures (Fig. 1) were identied as
cycleanine (1), isochondodendrine (2) (Fig. S3, S4, Tables S1 and
S2‡) and 20-norcocsuline (3) (Tables S3 and S4‡) on the basis of
spectroscopic data including electrospray ionization mass
spectrometry (ESI-MS), 1H NMR and 13C NMR spectroscopic
analysis in comparison with their spectroscopic data in the
literature.18,19 1H NMR and 13C NMR data of the TFA salt of 20-
norcocsuline exhibited slight diﬀerence from those of its free
base, 20-norcocsuline. Aer conversion of its TFA salt to its base
form, the observed 1H NMR and 13C NMR of 20-norcocsuline
were similar and comparable to the literature data for 20-nor-
cocsuline (Tables S3 and S4‡).19 Such eﬀect on chemical shis
by TFA was also observed for cycleanine.720-norcocsuline (3) from T. subcordata.
A2780 (A) and OVCAR-8 (B) cells, and 20-norcocsuline (3) in A2780 (C)
ts the medium control. The mean values of their IC50 are expressed as
RSC Adv., 2017, 7, 44154–44161 | 44155
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View Article OnlineCell growth assays of isochondodendrine and 20-norcocsuline
The activity of isochondodendrine and 20-norcocsuline isolated
from T. subcordata were determined in cell growth assays using
diﬀerent ovarian cancer cell lines (A2780, IGROV-1, OVCAR-8,
and OVCAR-4) (Fig. 2). The compounds inhibited growth of
the cultures with IC50 range of 3.5–17 mM (isochondodendrine)
and 0.8–6.2 mM (20-norcocsuline) respectively. Carboplatin and
paclitaxel were used as positive controls (Table 1). For
comparison, the IC50 in cell growth assays using normal human
ovarian epithelial (HOE) cells were 10.5  1.2 mM and 8.0 
0.2 mM for isochondodendrine and 20-norcocsuline, respec-
tively. The compounds showed somewhat greater potencies for
the cancer cells compared to normal cells (selectivity index (SI),
Table 1).
The trypan blue exclusion method was employed to distin-
guish cytotoxic and cytostatic eﬀects of the compounds in the
cell growth assays. The cell viability of A2780, IGROV-1, OVCAR-
8, and OVCAR-4 cells was reduced in a concentration-dependentTable 1 The potency of isochondodendrine (2) and 20-norcocsuline (3)
growth assays. The IC50 data are expressed as mean  SEM (n ¼ 5). Car
determined
Sample and SI
Cell lines/IC50  SEM (mM)
A2780 IGROV-1
Isochondodendrine (2) 3.5  0.1 9.0  0.5
SI against HOE 3.0 1.1
20-Norcocsuline (3) 2.9  0.1 0.8  0.1
SI 2.8 10
Carboplatin 8.0  0.7 12  0.9
Paclitaxel 0.0046 N.D.
Fig. 3 Eﬀects of isochondodendrine (2) and 20-norcocsuline (3) on the vi
IGROV-1, OVCAR-8, and OVCAR-4 cell lines, 48 h post-treatment with
isochondodendrine, or 20-norcocsuline at 5 mM (A), 10 mM (B) and 20 mM (
expressed as the percentage of the viability of cells in each sample and are
signiﬁcantly decreased in the treatment group, compared to control (P <
test).
44156 | RSC Adv., 2017, 7, 44154–44161manner aer 48 h treatment by isochondodendrine and
20-norcocsuline at the concentration of 5, 10 and 20 mM as well
as by the positive control carboplatin, when the four cancer cell
lines were exposed to the BBIQ alkaloids for 48 h (Fig. 3).Apoptosis
To evaluate whether the decrease in viability caused by iso-
chondodendrine (2) and 20-norcocsuline (3) was due to
increased apoptosis, the activation of caspase 3/7 by these
compounds was evaluated. Isochondodendrine and 20-norcoc-
suline caused a signicant increase in caspase activity in A2780,
IGROV-1, and OVCAR-8 cells (Fig. 4).
To conrm that the compounds induced apoptosis,
morphological changes, cleavage of poly(ADP-ribose) poly-
merase (PARP), and ow cytometry studies were performed.
OVCAR-8 was chosen for these studies because it was regarded
as a likely high-grade serous ovarian cancer cell line.20
Morphological alterations of OVCAR-8 cells treated withfrom T. subcordata in A2780, IGROV-1, OVCAR-8, and OVCAR-4 cell
boplatin and paclitaxel served as positive control. N.D. represents not
OVCAR-8 OVCAR-4 HOE
8.0  0.6 17  0.3 10.5  1.2
1.3 <1
1.9  0.2 6.2  0.5 8.0  0.2
4.2 1.3
16  1.1 N.D. N.D.
0.0058 0.0087 N.D.
ability of ovarian cancer cells. The percentages of viable cells of A2780,
medium (“control”), carboplatin (which served as a positive control),
C) were determined bymeasuring trypan blue exclusion. The results are
expressed asmean SEM (n¼ 3). The cell viability of each cell line was
0.05, one-way ANOVA with Dunnett's multiple comparison post hoc
This journal is © The Royal Society of Chemistry 2017
Fig. 4 Eﬀects on caspase 3/7 activity in ovarian cancer cells by isochondodendrine and 20-norcocsuline. Enzymatic activities of caspase 3/7 after
48 h treatment of A2780 (A), IGROV-1 (B) and OVCAR-8 (C) cells with medium as control, carboplatin, isochondodendrine and 20-norcocsuline.
The caspase activity is expressed as fold increase relative to control cells treated with drug solvent (mean SEM; n ¼ 6). This was analyzed using
one-way ANOVA with Dunnett's comparison post hoc test, *P < 0.05; **P < 0.001; ***P < 0.0001.
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View Article Onlineisochondodendrine and 20-norcocsuline showed membrane
blebbing, rounding up and cell detachment consistent with
apoptosis (Fig. S5‡). PARP cleavage, a marker of apoptosis, was
assessed by immunoblotting. Exposure of OVCAR-8 cells to
carboplatin, isochondodendrine and 20-norcocsuline resulted
in signicant PARP cleavage (Fig. 5).
To further quantify the percentage of apoptotic cells aer
treatment of these alkaloids, the OVCAR-8 cells were stained by
Annexin V and PI and analysed by ow cytometry (Fig. 6).
Treatment of OVCAR-8 cells with carboplatin, isochondoden-
drine or 20-norcocsuline for 48 h cells caused a signicant
increase of the population of both early and late apoptotic cells
(Fig. 6). 20-Norcocsuline was the strongest inducer among them.Cell cycle analysis
To assess whether isochondodendrine and 20-norcocsuline also
aﬀected cell cycle progression, OVCAR-8 cells were analysed byFig. 5 Western blot analysis of PARP cleavage in OVCAR-8 cells.
Treatment of OVCAR-8 cells after 48 h with carboplatin, iso-
chondodendrine and 20-norcocsuline caused cleavage of PARP.
GAPDH was used as a loading control.
This journal is © The Royal Society of Chemistry 2017ow cytometry aer staining cells with PI. However, the most
striking eﬀect was the increase in OVCAR-8 cells in subG1
population aer exposure to isochondodendrine and 20-nor-
cocsuline for 48 h compared to negative control (Fig. 7). Car-
boplatin, used as positive control known to induce apoptosis,
also caused an increase in the subG1 population.Discussion
The BBIQ alkaloids have been shown to possess a range of
biological activities, including cytotoxic,8,19,21,22 inhibition of
histamine release,23 antiplasmodial,24 and anti-leishmanial and
anti-trypanosomal eﬀects.25 A BBIQ alkaloid – cycleanine has
been isolated from T. subcordata and shown to exert cytotoxicity
through induction of apoptosis.7,8
In this study two additional minor BBIQ alkaloids-
isochondodendrine (2) and 20-norcocsuline (3) (Fig. 1), besides
the major cycleanine (1) from T. subcordata, were isolated and
characterized. The analytical data (ESI-MS and NMR) were
consistent with literature data for isochondodendrine18 and 20-
norcocsuline.19 To our surprise, the previously reported tri-
cordatine,11 fangchinoline,12 tetrandrine13 in 1970s from this
plant were not found by us in the present study. Those
compounds might be the trace components in our extract,
present as small peaks on HPLC (Fig. S2‡), or this discrepancy
might be due to the collection of plant materials from diﬀerent
locations and/or in diﬀerent seasons. Nevertheless, iso-
chondodendrine and 20-norcocsuline demonstrated anti-
ovarian cancer activity with potencies comparable to those we
have previously observed with cycleanine and tetrandrine.7,8
Both alkaloids showed more sensitivity to A2780, IGROV-1 and
OVCAR-8 cells than OVCAR-4 cells aer treatment for 72 h using
SRB assay (Fig. 2, Table 1). Although the pharmacokinetics of
these compounds remains to be dened, it is encouraging to
note that isochondodendrine showed similar potency to theRSC Adv., 2017, 7, 44154–44161 | 44157
Fig. 6 Flow cytometry analysis of apoptotic eﬀects of isochondodendrine and 20-norcocsuline on OVCAR-8 cells. The scatter dot plots indi-
cating the percentage of live (Annexin V negative, PI negative), early (Annexin V positive, PI negative) and late (Annexin V positive, PI positive)
apoptotic cells after treatment with medium (control) (A), carboplatin (B), isochondodendrine (C), and 20-norcocsuline (D) for 48 h by using
Annexin V & PI assay. The percentages of the total apoptotic cells induced by carboplatin, isochondodendrine, and 20-norcocsuline were
signiﬁcant compared to control (E) (one-way ANOVA with Dunnett's comparison post hoc test, *P < 0.05; **P < 0.001; ***P < 0.0001).
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View Article Onlineclinically used drug carboplatin, and 20-norcocsuline was more
potent than carboplatin in all four cancer cell lines. Previously,
20-norcocsuline, isolated from Anisocycla grandidieri, showed
cytotoxicity (IC50, 2.7 mM) against A2780 ovarian cancer cells,19
in agreement with our ndings. It seemed that the increase of
the hydrophilicity (more hydroxyl or amine groups in 2 and 3
than 1) increased the potency of these alkaloids.Fig. 7 Eﬀects of isochondodendrine and 20-norcocsuline on cell cycle o
isochondodendrine (C), and 20-norcocsuline (D) on the OVCAR-8 cell cy
phase (apoptotic cells) of the OVCAR-8 cell cycle was signiﬁcantly increa
cells) decreased signiﬁcantly compared to negative control (P < 0.0001
pendent experiments).
44158 | RSC Adv., 2017, 7, 44154–44161The cell viability was further measured with trypan blue,
which indicated that the two alkaloids (2 and 3) caused
concentration-dependent cell deaths in the four cancer cell
lines aer 48 h treatment (Fig. 3). Further experiments were
carried out for the detection of markers of apoptosis such as
caspases 3/7 and cleavage of PARP,7,26 and eﬀects on cell cycles
by these alkaloids aer treatment for 48 h. Both alkaloids and
carboplatin increased caspase 3/7 activity signicantly (Fig. 4),f OVCAR-8 cells. The eﬀects of medium (control) (A), carboplatin (B),
cle were analyzed by use of ﬂow cytometry. The percentage of subG1
sed compared to cells exposed to medium (E). While G0/G1 phase (live
, one-way ANOVA Dunnett's comparison post hoc test, n ¼ 5 inde-
This journal is © The Royal Society of Chemistry 2017
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View Article Onlineinduced PARP cleavage (Fig. 5) and the externalization of
phosphatidylserine at the cell surface (Fig. 6) in A2780, IGROV-1
and/or OVCAR-8 cell lines. It is known that caspase family
proteins are the executioners of apoptosis. Caspase cascades are
activated either through intrinsic (mitochondrial) pathway-
induced initiator caspase-9 or through extrinsic (death
receptor) apoptotic pathway-induced initiator caspase-8.26 Both
pathways eventually lead to the activation of caspase 3 and 7,
which cause the cleavage of structural and functional proteins
such as PARP as demonstrated above. The cell fraction of sub-
G1, a characteristic indicator of apoptosis, caused by iso-
chondodendrine and 20-norcocsuline was increased in ovarian
cancer cells (Fig. 7), which demonstrated the induction of
apoptosis.7,27 Taken together, this provided robust evidence that
these compounds induced apoptosis. It is also noteworthy that
other alkaloids which were isolated from the same plant
species, cycleanine and tetrandrine,7,8,13 also induced apoptosis.
Important questions such as what are the exact biological
targets of BBIQ alkaloids in cells causing downstream apoptosis
and how they regulate apoptosis and cell cycle remain to be
answered. BBIQ alkaloids such as tetrandrine have been shown
to specically bind a parallel G-quadruplex in vitro by electro-
spray ionization mass spectrometry,28,29 suggesting that the
mechanism of action of those compounds might include
interaction with DNA. However, tetrandrine and its derivatives
have also been shown to inhibit ATP-dependent eﬄux pump
P-glycoprotein activity and reverse the multidrug resistance in
human cancer cells.30,31 This suggests that BBIQ alkaloids could
induce their biological eﬀects through a variety of diﬀerent
pathways. Further work will be necessary and important to
identify the precise biological targets of these BBIQ alkaloids in
order to understand their mechanisms of action using cellular
thermal shi assay32 and/or a chemoproteomics approach.33 It
also raises the possibility that these compounds in particular 20-
norcocsuline (3) may be useful as starting points to develop
novel therapeutics to treat ovarian cancer if their mechanisms
are known. It is likely that modication (e.g. replacement of H-5
in 1 and 2 by halogen atoms31 or other functional groups) and
optimization of these compounds will be necessary to obtain
structure activity relationships and improve their potency,
selectivity and pharmacokinetics. This work is ongoing in our
laboratory and due to report.
Experimental
General
1H NMR (400 or 500 MHz), 13C NMR (125 MHz), and 2D-NMR
(COSY, HMQC and HMBC) spectra were obtained on a Bruker
400 or 500 MHz instruments. Chemical shis were reported in
d (ppm) using the solvents (CDCl3 + CD3OD) standard and
coupling constants (J) were measured in hertz. The high-
resolution mass spectra of the alkaloids were measured on
a Thermo Scientic Q-Exactive Orbitrap mass spectrometer
system using a HESI II electrospray ion source. Silica gel
(Sigma-Aldrich) was used as an adsorbent for ash column
chromatography. Dragendorﬀ's reagents were purchased from
Sigma-Aldrich.This journal is © The Royal Society of Chemistry 2017Plant material
T. subcordata root was collected from Orlu LGA, Imo state,
Nigeria. The plant material was identied by a taxonomist, H. D.
Onyeachusim. The voucher specimen (Voucher number:
UUH1817) was deposited at the herbarium of University of Uyo,
Akwa Ibom state, Nigeria. The root bark of the plant part was
made into powder and stored for solvent extraction.Extraction of T. subcordata
The 1.8 kg powdered root was extracted thrice by maceration
with 8 L of 5% acetic acid for 48 h (Fig. S1‡). The extracts were
combined and concentrated with a rotary evaporator. The crude
extract was subjected to alkaloid extraction, by alkalinization
with ammonium hydroxide (NH4OH; pH 9–10) and subsequent
partition with chloroform to yield total alkaloid extract (22.6 g).
Three pure alkaloids, cycleanine (1: 1.1%), isochondodendrine
(2: 0.1%) and 20-norcocsuline (3: 0.01%) (Fig. 1 and S2‡) were
isolated by using combined methods of silica gel column
chromatography, recrystallization and high performance liquid
chromatography (HPLC) procedure as previously described.7
Isochondodendrine (2), white powder, 1H and 13C NMR
(CDCl3 + CD3OD (1 : 1)) (Fig. S3, S4, Tables S1 and S2‡). Positive
HR-ESI-MS,m/z: 595.2807 (calcd mass for C36H39N2O6, [M + H]
+,
595.2808).
Triuoroacetic acid (TFA) salt of 20-norcocsuline (3), 1H and
13C NMR (CDCl3 + CD3OD (1 : 1)) see Tables S3 and S4.‡ Positive
HR-ESI-MS,m/z: 549.2384 (calcd mass for C34H33N2O5, [M + H]
+,
549.2389).
Conversion of TFA salt of 20-norcocsuline (3) to its free base,
20-norcocsuline$TFA salt was carried out by rst alkalinization
and subsequent extraction with chloroform to give its free base
form. 1H and 13C NMR (CDCl3 + CD3OD (1 : 1)) of free base form
3 are also listed Tables S3 and S4.‡Cell culture
The normal human ovarian epithelial (HOE) and human
ovarian cancer cell lines (A2780, IGROVE-1, OVCAR-8, and
OVCAR-4) cells were cultured in RPMI 1640 medium supple-
mented with 10% fetal bovine serum (FBS), penicillin-
streptomycin (50 U mL1), and glutamine (2 mM). All ovarian
cancer cell lines were products of American tissue culture
collection (ATCC). HOE cells were bought from Applied Bio-
logical Materials (ABM) Inc. HOE was originated from normal
ovarian epithelium and immortalized using SV40 large T
antigen.Cell growth assay
Cell growth inhibition assay was performed using sulforhod-
amine B (SRB) assay to determine the eﬀects of isochondoden-
drine (2), 20-norcocsuline (3), carboplatin (0.16–40 mM) and
control medium on the growth of ovarian cancer cell lines
(A2780, IGROV-1, OVCAR-8, and OVCAR-4) and normal HOE
cells aer treatment for 72 h.7,34 The principle of SRB assay
used for the determination of cell density is based on the
measurement of live cellular protein content. Briey, 5000 cellsRSC Adv., 2017, 7, 44154–44161 | 44159
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View Article Online(IGROV-1, OVCAR-4, or HOE), and 2000 cells (OVCAR-8 and
A2780) in 80 ml of growth medium were seeded in a 96-well
plate. Aer 24 h 20 ml of the two alkaloids and carboplatin
dissolved in DMSO (nal concentration 0.2%) were added. Aer
72 h themediumwas removed and the cells were xed with 10%
TCA before being stained with 0.4% SRB in 1% acetic acid. Aer
washing with 1% acetic acid, the protein-dye complexes were
dissolved in 10 mM Tris-base solution for OD determination at
570 nm using a microplate reader.34 The IC50s were determined
using GraphPad Prism 6 soware.
Cell counting
The viability of ovarian cancer cells was measured using trypan
blue exclusion method before seeding cells and aer treatment
of A2780, IGROV-1, OVCAR-8, and OVCAR-4 cells (200, 000 cells
per ml) with alkaloids 2 and 3 (5, 10 and 20 mM) for 48 h as
previously described using a Countess cell counter.7
Caspase-Glo 3/7 activity assay
The eﬀect of isochondodendrine and 20-norcocsuline on the
caspase-3/7 activities in A2780, IGROV-1, and OVCAR-8 cells was
carried out using assay kits Caspase-Glo 3/7 (Promega Corp.,
Madison, WI, USA) on a 96-well microplate, as described
previously.7 Briey, IGROV-1 and OVCAR-4 (5000 cells per well),
A2780 and OVCAR-8 (2000 cells per well) cells were incubated in
80 mL growth medium in a 96-well plate for 24 h. Cells were then
supplemented with growth medium (control), carboplatin, iso-
chondodendrine and 20-norcocsuline (20 mM) for 48 h. An
inverted light microscope was used to capture the morpholog-
ical images before adding Caspase-Glo 3/7 reagent agents to the
cell culture. Aer incubating at room temperature for 30 min in
the dark, the optical reading was measured at 570 nm.
Western blot assay
To evaluate apoptosis caused by isochondodendrine and 20-
norcocsuline in OVCAR-8 cells, western blot assay was carried
out according to described procedure.7 Briey, 200 000 OVCAR-
8 cells per ml were seeded in a six-well plate and were treated
with isochondodendrine, 20-norcocsuline, carboplatin (20 mM),
or medium for 48 h. The cells were collected by trypsinization
and lysed. The extracted proteins were resolved on 4–20%
Tris–glycine polyacrylamide gradient gel (Nusep). Aer electro-
phoresis, the proteins were transferred to a polyvinylidene
uoride membrane. The membrane was rst washed with
buﬀer containing 5% skimmed milk powder and then probed
with antibodies against poly(ADP-ribose) polymerase (PARP) for
16 h at 4 C overnight or glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) from mouse (1 : 5000) for 1 h at room
temperature. Proteins were visualized using UptiLight HRP
chemiluminescent substrate on a FluorChem M system.
Flow cytometry analysis
The eﬀect on cell cycle of OVCAR-8 cells by isochondodendrine
and 20-norcocsuline using propidium iodide (PI) was assayed
according to the published procedures.7 Briey, OVCAR-8 (1 44160 | RSC Adv., 2017, 7, 44154–44161106 cells per ml) cells aer treatment of carboplatin and the two
alkaloids (20 mM) for 48 h were trypsinized, xed with 70%
ethanol and stained with PI. The stained cells were measured by
ow cytometry to score the DNA content. The percentages of
cells in the SubG1, G0/G1, S and G2/M cell cycle phases were
determined using FLOWING soware.
The apoptosis assay using uorescein isothiocyanate (FITC)-
conjugated Annexin V to label cell-surface phosphatidylserine
of apoptotic cells and PI to label DNA content was also carried
out using the procedure described previously.7 Briey, OVCAR-8
cells (300 000 cells per ml) aer treatment of carboplatin, iso-
chondodendrine and 20-norcocsuline (20 mM) for 48 h were
trypsinized, and stained with Annexin V–FITC dye and PI. The
cells were measured by ow cytometry. The percentages of live
cells, dead, early and late apoptotic cells were determined using
FLOWING soware.
Statistical analysis
The results were presented as mean values  SEM. One-way
analysis of variance (ANOVA) with Dunnett's (multiple)
comparison post hoc test was used for the determination of
statistical signicance of diﬀerence between means. P-Values
<0.05 were considered statistically signicant. All analyses were
performed using GraphPad Prism soware 6.0.
Conclusion
This study identies isochondodendrine and 20-norcocsuline as
minor and bioactive constituents of T. subcordata, which serves
to further explain the in vitro anti-cancer activity via induction
of apoptosis and interference of cell cycle. These results provide
a new source of cytotoxic alkaloids and support its traditional
use of T. subcordata in cancer treatment.
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